Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59649-4 N-desalkylflurazepam MCnc Body fld Pt Qn Confirm   ACTIVE N-desalkylflurazepam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59649-4   Confirm     Both       0 Desalkylfluraz Fld Cfm-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Flurazepam metabolite; GCMS; LC/MS/MS; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
5965-9 Plasmin inhibitor ACnc PPP Pt Qn Chromo   ACTIVE Plasmin inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method   MIN DefinitionDescription     arb U/mL             COAG   5965-9   Chromo     Both       0 Plasm Inhib PPP Chro-aCnc       Y   Alpha-2-anti plasmin; Alpha-2-antiplasmin; Alpha-2-AP; Antiplasmin; Arbitrary concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Inhib; Inhibit; Plas; Plasm Inhib; Platelet poor plasma; Point in time; Primary fibrinolysis inhibitor; Primary plasmin inhibitor; QNT; Quan; Quant; Quantitative; Random 2.73 1.0d               [arb'U]/mL       0
59650-2 N-desalkylflurazepam MCnt Meconium Pt Qn Confirm   ACTIVE N-desalkylflurazepam [Mass/mass] in Meconium by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59650-2   Confirm     Both       0 Desalkylfluraz Mec Cfm-mCnt       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; LC/MS/MS; Mass content; Mec; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/g       0
59651-0 N-desalkylflurazepam MCnt Stool Pt Qn Confirm   ACTIVE N-desalkylflurazepam [Mass/mass] in Stool by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59651-0   Confirm     Both       0 Desalkylfluraz Stl Cfm-mCnt       N   Bowel movement; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Flurazepam metabolite; GCMS; LC/MS/MS; Mass content; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal 2.7 2.32               ng/g       0
59652-8 N-desalkylflurazepam MCnt Tiss Pt Qn     ACTIVE N-desalkylflurazepam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59652-8         Both       0 Desalkylfluraz Tiss-mCnt       N   Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Mass content; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.73 2.32               ng/g       0
59653-6 N-desalkylflurazepam MCnt Tiss Pt Qn Confirm   ACTIVE N-desalkylflurazepam [Mass/mass] in Tissue by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59653-6   Confirm     Both       0 Desalkylfluraz Tiss Cfm-mCnt       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; LC/MS/MS; Mass content; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
59654-4 diazePAM MCnc Bld Pt Qn     ACTIVE diazePAM [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59654-4         Both       0 diazePAM Bld-mCnc       N   Addiction; Blood; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium; WB; Whole blood 2.7 2.32               ng/mL       0
59655-1 diazePAM MCnc Bld Pt Qn Confirm   ACTIVE diazePAM [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59655-1   Confirm     Both       0 diazePAM Bld Cfm-mCnc       N   Addiction; Blood; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium; WB; Whole blood 2.73 2.32               ng/mL       0
59656-9 diazePAM MCnc Body fld Pt Qn     ACTIVE diazePAM [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59656-9         Both       0 diazePAM Fld-mCnc       N   Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium 2.7 2.32               ng/mL       0
59657-7 diazePAM MCnc Body fld Pt Qn Confirm   ACTIVE diazePAM [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59657-7   Confirm     Both       0 diazePAM Fld Cfm-mCnc       N   Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium 2.7 2.32               ng/mL       0
59658-5 diazePAM MCnt Meconium Pt Qn Confirm   ACTIVE diazePAM [Mass/mass] in Meconium by Confirmatory method   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59658-5   Confirm     Both       0 diazePAM Mec Cfm-mCnt       N   Addiction; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Mass content; Mec; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium 2.7 2.32               ng/g       0
59659-3 diazePAM MCnt Stool Pt Qn Confirm   ACTIVE diazePAM [Mass/mass] in Stool by Confirmatory method   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59659-3   Confirm     Both       0 diazePAM Stl Cfm-mCnt       N   Addiction; Bowel movement; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; GCMS; Illicit; LC/MS/MS; Mass content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Stl; Stool = Fecal; Valium 2.7 2.32               ng/g       0
5966-7 Plasmin inhibitor Ag MCnc PPP Pt Qn IA   ACTIVE Plasmin inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay   MIN DefinitionDescription                   COAG   5966-7   IA     Both       0 Plasm Inhib Ag PPP IA-mCnc       Y   Alpha-2-anti plasmin; Alpha-2-antiplasmin; Alpha-2-AP; Antigen; Antigens; Antiplasmin; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Inhib; Inhibit; Level; Mass concentration; MEIA; Plas; Plasm Inhib; Platelet poor plasma; Point in time; Primary fibrinolysis inhibitor; Primary plasmin inhibitor; QNT; Quan; Quant; Quantitative; Random; SUDS 2.73 1.0d                     Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). 0
59660-1 diazePAM MCnt Tiss Pt Qn     ACTIVE diazePAM [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59660-1         Both       0 diazePAM Tiss-mCnt       N   Addiction; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Tissue; Tissue, unspecified; Valium 2.7 2.32               ng/g       0
59661-9 diazePAM MCnt Tiss Pt Qn Confirm   ACTIVE diazePAM [Mass/mass] in Tissue by Confirmatory method   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59661-9   Confirm     Both       0 diazePAM Tiss Cfm-mCnt       N   Addiction; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Mass content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Tissue; Tissue, unspecified; Valium 2.7 2.32               ng/g       0
59662-7 Diclofenac MCnc Bld Pt Qn     ACTIVE Diclofenac [Mass/volume] in Blood   MIN DefinitionDescription     ug/mL 0.1 mcg/mL           DRUG/TOX   59662-7         Both       0 Diclofenac Bld-mCnc       N   Blood; c215; c281; C52; Cambia; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltaren optha; Voltaren opthalmic; WB; Whole blood 2.7 2.32               ug/mL       0
59663-5 Diclofenac MCnc Urine Pt Qn     ACTIVE Diclofenac [Mass/volume] in Urine   MIN DefinitionDescription     ug/mL 0.1 mcg/mL           DRUG/TOX   59663-5         Both       0 Diclofenac Ur-mCnc       N   c215; c281; C52; Cambia; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Voltaren optha; Voltaren opthalmic 2.73 2.32               ug/mL       0
59664-3 Estazolam MCnc Bld Pt Qn     ACTIVE Estazolam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59664-3         Both       0 Estazolam Bld-mCnc       N   Blood; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
59665-0 Estazolam MCnc Bld Pt Qn Confirm   ACTIVE Estazolam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59665-0   Confirm     Both       0 Estazolam Bld Cfm-mCnc       N   Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; GCMS; LC/MS/MS; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
59666-8 Estazolam MCnc Body fld Pt Qn     ACTIVE Estazolam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59666-8         Both       0 Estazolam Fld-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Fl; Fld; FLU; Fluid; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59667-6 Estazolam MCnc Body fld Pt Qn Confirm   ACTIVE Estazolam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59667-6   Confirm     Both       0 Estazolam Fld Cfm-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Fl; Fld; FLU; Fluid; GCMS; LC/MS/MS; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59668-4 Estazolam MCnc Ser/Plas Pt Qn Confirm   ACTIVE Estazolam [Mass/volume] in Serum or Plasma by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59668-4   Confirm     Both       0 Estazolam SerPl Cfm-mCnc       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; GCMS; LC/MS/MS; Level; Mass concentration; Nuctalon; Pl; Plasma; Plsm; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.7 2.32               ng/mL       0
59669-2 Estazolam MCnt Stool Pt Qn Confirm   ACTIVE Estazolam [Mass/mass] in Stool by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59669-2   Confirm     Both       0 Estazolam Stl Cfm-mCnt       N   Bowel movement; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Faecal; Faeces; Fecal; Feces; GCMS; LC/MS/MS; Mass content; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal 2.7 2.32               ng/g       0
5967-5 Plasmin inhibitor Ag ACnc PPP Pt Qn IA   ACTIVE Plasmin inhibitor Ag [Units/volume] in Platelet poor plasma by Immunoassay   MIN DefinitionDescription                   COAG   5967-5   IA     Both       0 Plasm Inhib Ag PPP IA-aCnc       Y   Alpha-2-anti plasmin; Alpha-2-antiplasmin; Alpha-2-AP; Antigen; Antigens; Antiplasmin; Arbitrary concentration; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Inhib; Inhibit; MEIA; Plas; Plasm Inhib; Platelet poor plasma; Point in time; Primary fibrinolysis inhibitor; Primary plasmin inhibitor; QNT; Quan; Quant; Quantitative; Random; SUDS 2.69 1.0d               [arb'U]/mL     Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). 0
59670-0 Estazolam MCnt Tiss Pt Qn     ACTIVE Estazolam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59670-0         Both       0 Estazolam Tiss-mCnt       N   DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Mass content; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
104,672 results found